Urologix, Inc. announced preliminary unaudited revenue results for the third quarter ended March 31, 2014. Third quarter fiscal year 2014 revenue totaled $3.4 million, down 12% compared to the second quarter of fiscal year 2014 and down 18% compared to the prior year's results.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -.--% |
2016 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
2015 | Urologix Conducting A Strategic Review | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.13K | |
+12.50% | 228B | |
+14.52% | 196B | |
+17.51% | 141B | |
+28.96% | 110B | |
+3.27% | 65.88B | |
+18.16% | 54.3B | |
+7.63% | 52.39B | |
+10.95% | 45.22B | |
+5.10% | 37.12B |
- Stock Market
- Equities
- ULGX Stock
- News Urologix, Inc.
- Urologix, Inc. Announces Preliminary Unaudited Revenue Results for the Third Quarter Ended March 31, 2014